Clarithromycin adjunct treatment leads to substantial financial savings in community-acquired pneumonia: sub-analysis of the ACCESS trial

Clarithromycin adjunct treatment leads to substantial financial savings in community-acquired pneumonia: sub-analysis of the ACCESS trial

BACKGROUND: In the ACCESS randomized controlled trial addition of oral clarithromycin 500mg two times daily for seven days to standard-of-care (SoC) antibiotics provided substantial clinical benefit in adult patients hospitalized for community-acquired pneumonia (CAP) including early clinical respon...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasiliki Rapti, Elisavet Tasouli, Antigone Kotsaki, Georgios Niotis, Marios Chatzopoulos, Eirini Christaki, Evangelos J. Giamarellos Bourboulis, Garyphalia Poulakou
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
pneumonia
clarithromycin
cost
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524001917
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524001917

Similar Items